Goodwin Procter advised Eluminex Biosciences on the deal. Eluminex Biosciences (Suzhou) Limited (Eluminex) announced its acquisition of certain assets and the related global development and commercialization rights...
Eluminex Biosciences’ Acquisition of Zuretinol Acetate Assets from Retinagenix
Generate Biomedicines’ Research Collaboration Agreement with Amgen
Goodwin advised Generate Biomedicine on the deal. Generate Biomedicines announced its research collaboration agreement with Amgen (NASDAQ: AMGN) to discover and create protein therapeutics for five clinical...
Qilu Pharmaceutical’s Licensing Agreement and Partnership with Arbutus Biopharma Corporation
Goodwin Procter advised Qilu Pharmaceutical on the deal. Qilu Pharmaceutical, one of the leading pharmaceutical companies in China (“Qilu”), announced its exclusive licensing agreement and strategic partnership...
Cint Group AB’s $1.07 Billion Acquisition of Lucid
Kirkland & Ellis and Gernandt & Danielsson advised Cint Group AB on the deal, while Goodwin Procter represented Lucid Holdings, LLC. Cint Group AB (publ), a...
Marvell Technology’s Acquisition of Innovium
Goodwin Procter advised Innovium on the deal. Innovium announced its acquisition by Marvell Technology (NASDAQ: MRVL) in an all-stock transaction, which closed on October 5, 2021. Under...
Sinch AB’s $1.9 Billion Acquisition of Pathwire
Goodwin Procter advised Pathwire on the deal, while K&L Gates and Gernandt & Danielsson advised Sinch AB. Pathwire, along with its private equity owner Thoma Bravo...
Laronde’s $440 Million Series B Financing
Goodwin Procter advised Laronde on the deal. Laronde announced its $440 million Series B Financing to advance the development of its eRNA platform and a broad pipeline...
Nimbus Therapeutics’ $105 Million Private Financing Round
Goodwin Procter LLP advised Nimbus Therapeutics on the deal. Nimbus Therapeutics announced the closing of a $105 million private financing round which was led by BVF Partners...
2U’s $800 Million Acquisition of edX
Paul Hastings advised 2U, Inc. on the deal while Goodwin Procter represented edX. 2U, Inc., a global leader in education technology, announced a definitive agreement to acquire...
Cambridge Mobile Telematics’ Acquisition of TrueMotion
Goodwin Procter LLP advised TrueMotion on the deal. TrueMotion announced its acquisition by Cambridge Mobile Telematics. The transaction, which closed on June 16, unites the two leading...
Datavant Inc.’s Merger with Ciox Health LLC
Sidley Austin advised Sixth Street and Goldman Sachs on the deal while Goodwin Procter LLP represented Datavant. Ropes & Gray represented New Mountain Capital and its...
Valo Health’s $2.8 Billion Merger with Khosla Ventures Acquisition Co.
Goodwin Procter LLP advised Valo Health on the deal, while Latham & Watkins LLP represented Khosla Ventures Acquisition Co. Valo Health announced its definitive merger agreement with...